TP53 and renal carcinoma: In the literature, SRP19 and DNPEP have been related to p53 activity, inhibition of metastasis, inflammation, and cell proliferation [37,38]; while COG5 mitigates endoplasmic reticulum stress [39] and DHFR2 is considered a favorable prognostic marker in renal cancer [30].